The Attenuating Effects of Plumbagin on Pro-inflammatory Cytokine Expression in LPS-activated BV-2 Microglial Cells

Overview

Journal J Neuroimmunol

Specialty Neurology

Date 2017 Sep 28

PMID 28950995

Citations 12

Authors

Samia S Messeha

Najla O Zarmouh

Patricia Mendonca

Malak G Kolta

Karam F A Soliman

Affiliations

Soon will be listed here.

Abstract

Activated microglial cells produce the pro-inflammatory mediators such as nitric oxide (NO) and cytokines. The excessive release of these mediators can lead to neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD). Inhibition of the release of these pro-inflammatory molecules may prevent or halt the progression of these diseases. Plumbagin (PL), a naphthoquinone compound in the roots of the traditional medicinal plant Plumbago zeylanica L., showed anti-inflammatory effects on macrophages. However, PL effects on activated microglia remain unknown. In the present study, PL has been examined for its anti-inflammatory effect on LPS - activated microglial BV-2 cells. In this study, NO and iNOS expression were investigated in BV-2 microglial cells in the presence of PL or the selective iNOS inhibitor L-N6-(1-iminoethyl) lysine (L-NIL). The results obtained indicate that PL was >30-fold potent than L-NIL in inhibiting NO production with an IC of 0.39μM. Our immunofluorescence study confirmed the ability of PL to significantly inhibit iNOS expression in the activated microglia. Furthermore, the extracellular microglial pro-inflammatory cytokine expression in the presence of 2μM of PL was detected, quantified, and validated using cytokine antibody protein arrays and quantitative ELISA. The results obtained showed that PL significantly downregulated the expression of many cytokines including IL-1α, G-CSF, IL-12 p40/p70, MCP-5, MCP-1, and IL-6. In conclusion, PL potency in attenuating multiple pro-inflammatory agents indicates its potential to be used for neurodegenerative diseases.

Citing Articles

Pharmacological Features and Therapeutic Implications of Plumbagin in Cancer and Metabolic Disorders: A Narrative Review.

Sharma B, Dhiman C, Hasan G, Shamsi A, Hassan M Nutrients. 2024; 16(17).

PMID: 39275349 PMC: 11397539. DOI: 10.3390/nu16173033.

Plumbagin ameliorates LPS-induced acute lung injury by regulating PI3K/AKT/mTOR and Keap1-Nrf2/HO-1 signalling pathways.

Liu Z, Wei J, Sun H, Xu L J Cell Mol Med. 2024; 28(13):e18386.

PMID: 38990057 PMC: 11238321. DOI: 10.1111/jcmm.18386.

Naphthoquinones as a Promising Class of Compounds for Facing the Challenge of Parkinson's Disease.

Santos T, de Moraes L, Furtado Pacheco P, Dos Santos D, Ribeiro R, Moreira C Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004442 PMC: 10674926. DOI: 10.3390/ph16111577.

Plumbagin, a Natural Compound with Several Biological Effects and Anti-Inflammatory Properties.

Petrocelli G, Marrazzo P, Bonsi L, Facchin F, Alviano F, Canaider S Life (Basel). 2023; 13(6).

PMID: 37374085 PMC: 10301567. DOI: 10.3390/life13061303.

Plumbagin relieves rheumatoid arthritis through nuclear factor kappa-B (NF-κB) pathway.

Shu C, Chen J, Lv M, Xi Y, Zheng J, Xu X Bioengineered. 2022; 13(5):13632-13642.

PMID: 35653787 PMC: 9276045. DOI: 10.1080/21655979.2022.2081756.

References

Lull M, Block M . Microglial activation and chronic neurodegeneration. Neurotherapeutics. 2010; 7(4):354-65. PMC: 2951017. DOI: 10.1016/j.nurt.2010.05.014. View

Sonobe Y, Yawata I, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A . Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res. 2005; 1040(1-2):202-7. DOI: 10.1016/j.brainres.2005.01.100. View

Kettenmann H, Hanisch U, Noda M, Verkhratsky A . Physiology of microglia. Physiol Rev. 2011; 91(2):461-553. DOI: 10.1152/physrev.00011.2010. View

Nicoletti F, Patti F, Cocuzza C, Zaccone P, Nicoletti A, Di Marco R . Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis. J Neuroimmunol. 1996; 70(1):87-90. DOI: 10.1016/s0165-5728(96)00101-4. View

Glass C, Saijo K, Winner B, Marchetto M, Gage F . Mechanisms underlying inflammation in neurodegeneration. Cell. 2010; 140(6):918-34. PMC: 2873093. DOI: 10.1016/j.cell.2010.02.016. View

Xu J, Racke M, Drew P . Peroxisome proliferator-activated receptor-alpha agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis. J Neurochem. 2007; 103(5):1801-10. PMC: 2288776. DOI: 10.1111/j.1471-4159.2007.04875.x. View

Wang T, Wu F, Jin Z, Zhai Z, Wang Y, Tu B . Plumbagin inhibits LPS-induced inflammation through the inactivation of the nuclear factor-kappa B and mitogen activated protein kinase signaling pathways in RAW 264.7 cells. Food Chem Toxicol. 2013; 64:177-83. DOI: 10.1016/j.fct.2013.11.027. View

Sun D, Tani M, Newman T, Krivacic K, Phillips M, Chernosky A . Role of chemokines, neuronal projections, and the blood-brain barrier in the enhancement of cerebral EAE following focal brain damage. J Neuropathol Exp Neurol. 2001; 59(12):1031-43. DOI: 10.1093/jnen/59.12.1031. View

Wang H, Zhang H, Zhang Y, Wang D, Cheng X, Yang F . Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production. Oncotarget. 2016; 7(50):82864-82875. PMC: 5347738. DOI: 10.18632/oncotarget.12655. View

10.

Sunil C, Duraipandiyan V, Agastian P, Ignacimuthu S . Antidiabetic effect of plumbagin isolated from Plumbago zeylanica L. root and its effect on GLUT4 translocation in streptozotocin-induced diabetic rats. Food Chem Toxicol. 2012; 50(12):4356-63. DOI: 10.1016/j.fct.2012.08.046. View

11.

Aziz M, Dreckschmidt N, Verma A . Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Res. 2008; 68(21):9024-32. PMC: 2584362. DOI: 10.1158/0008-5472.CAN-08-2494. View

12.

Jellinger K, Stadelmann C . Problems of cell death in neurodegeneration and Alzheimer's Disease. J Alzheimers Dis. 2002; 3(1):31-40. DOI: 10.3233/jad-2001-3106. View

13.

Garwood C, Cooper J, Hanger D, Noble W . Anti-inflammatory impact of minocycline in a mouse model of tauopathy. Front Psychiatry. 2011; 1:136. PMC: 3059645. DOI: 10.3389/fpsyt.2010.00136. View

14.

Thasni K, Rakesh S, Rojini G, Ratheeshkumar T, Srinivas G, Priya S . Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents. Ann Oncol. 2008; 19(4):696-705. DOI: 10.1093/annonc/mdm557. View

15.

Gomathinayagam R, Sowmyalakshmi S, Mardhatillah F, Kumar R, Akbarsha M, Damodaran C . Anticancer mechanism of plumbagin, a natural compound, on non-small cell lung cancer cells. Anticancer Res. 2008; 28(2A):785-92. View

16.

Khaw A, Sameni S, Venkatesan S, Kalthur G, Hande M . Plumbagin alters telomere dynamics, induces DNA damage and cell death in human brain tumour cells. Mutat Res Genet Toxicol Environ Mutagen. 2015; 793:86-95. DOI: 10.1016/j.mrgentox.2015.06.004. View

17.

Dhingra D, Bansal S . Antidepressant-like activity of plumbagin in unstressed and stressed mice. Pharmacol Rep. 2015; 67(5):1024-32. DOI: 10.1016/j.pharep.2015.03.001. View

18.

Jetty A, Subhakar C, Rajagopal D, Jetty M, Subramanyam M, Marthanda Murthy M . Antimicrobial activities of neo- and 1-epineo-isoshinanolones from Plumbago zeylanica roots. Pharm Biol. 2010; 48(9):1007-11. DOI: 10.3109/13880200903433760. View

19.

Taka E, Mazzio E, Goodman C, Redmon N, Flores-Rozas H, Reams R . Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells. J Neuroimmunol. 2015; 286:5-12. PMC: 4548297. DOI: 10.1016/j.jneuroim.2015.06.011. View

20.

Nakamura H, Ueki Y, Sakito S, Matsumoto K, Yano M, Miyake S . High serum and synovial fluid granulocyte colony stimulating factor (G-CSF) concentrations in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2001; 18(6):713-8. View